Wellmark, Hy-Vee, UnityPoint Collaborate on Health Plans

West Des Moines, Iowa-based UnityPoint Health has joined forces with health insurer Wellmark Blue Cross and Blue Shield and the supermarket chain Hy-Vee to offer a new health insurance product designed to promote coordinated care and encourage healthy behavior.

Advertisement

The health plan, Blue RewardsSM, will be available to individuals and small businesses through the Iowa Patient Protection and Affordable Care Act exchange starting this fall. The insurance product combines the coordinated care offered by UnityPoint Health’s provider network and pharmacy, health food, wellness and dietician services from Hy-Vee in a plan administered by Wellmark, according to a news release.

Although plan members will have access to Wellmark’s full provider network, they will have the lowest out-of-pocket costs if they receive care from UnityPoint providers and fill prescriptions at Hy-Vee pharmacies. Blue Rewards still requires regulatory approval, according to the release.

More Articles on Health Insurance Coverage:
Federal Exchange Plans to Automatically Renew in 2015 Under Proposed Rule  
AHA: 5 Key Strategies for Hospitals to Succeed in the New Healthcare Marketplace  
Oregon’s Insurance Exchange Website Fell Prey to Political Motives, Oracle Says 

 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.